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infected Taiwanese patients with higher plasma EFV concentrations who
had achieved viral suppression could maintain successful viral suppression
with the guidance of TDM and save medical cost.
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TRENDS AND OUTCOME OF HIV-POSITIVE PATIENTS WITH LATE
PRESENTATION FOR COMBINATION ANTIRETROVIRAL THERAPY IN
TAIWAN: A COHORT STUDY
Chien-Ching Hung 1, Mao-Song Tsai 2, Sui-Yuan Chang 1. 1National Taiwan
University Hospital, Taiwan; 2Far Eastern Memorial Hospital, New Taipei
City, Taiwan
Purpose: We aimed to assess the trends of late presentation for combination
antiretroviral therapy (cART) and evaluate its impact on treatment response
to cART in Taiwan, where nationwide access to free-of-charge cART and CD4
and plasma HIV RNA load (PVL) monitoring is provided.
Methods: Between June 2012 and October, 2014, we followed all antiretro-
viral-naive HIV-positive adults who initiated cART at a university hospital in
Taiwan. We collected the information on demographic and clinical charac-
teristics, antiretroviral regimens, and CD4 and PVL at baseline and weeks
4, 12, 24, 36 and 48. Late presentation for cART was initiation of cART at
CD4 counts <200 cells/mm3. Genotypic resistance assays were performed
retrospectively on the HIV-1 isolates from the archived blood samples taken
before cART. Antiretroviral resistance mutations were identified using the
HIVdb program of the Stanford University HIV Drug Resistance Database.
Multidrug resistance (MDR) was defined as having genotypic resistance to
more than one class of antiretroviral agents.
Results: During the study period, 621 HIV-positive patients, 97.3% being
male and with a mean age of 32.7 years, initiated cART. The baseline CD4
and PVL was 279 cells/mm3 (SD, 179) and 4.9 log10 (SD, 0.7) copies/ml,
respectively. The overall proportion of late presentation for cART was
31.7%, which decreased from 45.9% in the first 6-month period to 19.5% in
the last 5-month period. Compared with non-late presenters, late pre-
senters were older (37.1 vs 30.1 years), more likely to be heterosexual
(8.6 vs 3.1%) and HBsAg-positive (16.5 vs 7.8%), and to have higher PVL
(5.28 vs 4.71 log10 copies/ml) and aminotransferases, and more patients
with opportunistic infections (15.2 vs 0.5%), leukopenia (30.3 vs 9.3%),
and hemoglobin <9 g/dl (7.6 vs 0.7%). Genotypic resistance to any NRTI
and integrase inhibitor and MDR strains was more commonly seen in late
presenters than non-late presenters: NRTI, 8.3 vs 2.3%; integrase inhibitor,
9.2 vs 3.7%; and MDR, 2.7 vs 0.4%. Genotypic resistance to nNRTI (6.3 vs
7.4%) or PI (2.8 vs 1.2%) was not significantly different between the two
groups. A similar proportion of the patients initiated nNRTI-containing reg-
imens (92.9 vs 93.6%). Within the first 24 weeks of cART, more late pre-
senters had to switch regimens than non-late presenters for any causes
(54.6 vs 48.1%) and for resistance or unsatisfactory virological response
(12.6 vs 5.5%). While the proportions of patients achieving PVL<400
copies/ml at week 24 were insignificantly lower with regimen changes
made (91.2 vs 95.4%), late presenters had a higher mortality rate than
non-late presenters (3.5 vs 0.7%).
Conclusions: In Taiwan, the proportion of HIV-positive patients who pre-
sented late for cART was decreasing. Late presenters had more unfavorable
clinical and virological characteristics that might contribute to the increased
probability of switching cART and mortality once cART was begun.
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HEALTHCARE UTILIZATION ASSOCIATED WITH INFLUENZA LIKE ILLNESS:
A SURVEY IN THE GENERAL POPULATION OF HONG KONG
Lin Yang 1,*, Lorna KP. Suen 1, Margaret O’Donoghue 1, Chit Ming Wong 2,
Qiuyan Liao 2. 1School of Nursing, The Hong Kong Polytechnic University;
2School of Public Health, The University of Hong Kong
Purpose: Influenza is one of most common respiratory viruses circulating in
human populations. However, there are no reliable data on healthcare utili-
zation of relatively mild cases in terms of visiting outpatient clinics or by
self-medication, especially in subtropical and tropical regions whereinfluenza could be active throughout the year. In this study we conducted
a telephone survey in the Hong Kong general population to estimate the inci-
dence of influenza-like symptoms (at least one of following symptoms:
fever>38C, cough or sore throat), and also to obtain the risk of outpatient
visits and hospitalizations after showing these symptoms.
Methods: A telephone survey was conducted during the summer peak of
influenza, by randomly dialing the household telephone numbers. The
data of self-report incidence rates of influenza-like symptoms, healthcare
utilization, vaccination history, demographic and lifestyle factors were
collected.
Results: During 28 July e17 August 2014, we successfully interviewed 516
people aged above 18 years in Hong Kong. 141 subjects (27.3%) reported hav-
ing fever, cough or sore throat in the month before interview. Among these
people, 7, 36 and 17 (4.6%, 25.5% and 12.3%) visited the private hospitals,
private clinics and private Chinese medicine practitioners for the influ-
enza-like symptoms. The visits to the public healthcare settings were 5.0%
and 17.1% for Acute & Emergency and General Outpatient Clinics, respec-
tively. Among 331 people with valid vaccination history data, 10.9% reported
to have received influenza vaccination in the last season. The percentages of
self-report influenza-like symptoms were 50.0% and 41.8% among those who
had or had not been vaccinated, respectively. But the difference was not
statistically significant (p > 0.05). In 155 households with children aged
below 18 years, 32.9% had influenza-like symptoms in the month before
interview. Among 69 households with vaccination reported for interviewed
children, the vaccination coverage is 15.9%. The incidence rate of influ-
enza-like symptoms was 81.8% and 69.8% in children who had or had not
been vaccinated, respectively. But the difference was not statistically
significant.
Conclusions: Influenza is associated with a heavy burden of morbidity in the
summer epidemic period in subtropical Hong Kong. The findings of this study
are important for proper assessment of disease severity, evaluation of con-
trol measure effectiveness and cost-effectiveness analysis of vaccination
strategies. Future studies in winter epidemic periods are needed to obtain
the comprehensive estimates on severity profile and economic burden of
influenza.
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MOLECULAR DETERMINANTS OF HUMAN DEFENSE AGAINST AVIAN
INFLUENZA VIRUS INFECTION
Shu-Ming Kuo 1, Chi-Jene Chen 1, Shih-Cheng Chang 1,2, Guang-Wu Chen 1,3,
Tzu-Jou Liu 1, Hsin-Ping Chiu 1, Rei-Lin Kuo 1, Shin-Ru Shih 1,2,*. 1Research
Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan,
Taiwan; 2Clinical Virology Laboratory, Chang Gung Memorial Hospital, Tao-
Yuan, Taiwan; 3Department of Computer Science and Information
Engineering, Chang Gung University, Tao-Yuan, Taiwan
Purpose: Avian influenza A viruses typically do not efficiently replicate in
mammalian cells. The substitution of glutamic acid (E) for lysine (K) at res-
idue 627 of the viral polymerase basic 2 (PB2) of avian H5N1 viruses has been
identified as a host-range and virulence determinant for mammal infection.
Although the PB2 627 variation is regarded as a species-specific signature of
influenza A viruses, host factors associated with PB2 627 have not been fully
investigated. Therefore, investigating the mechanisms through which viruses
shift their host tropism is critical for preventing and controlling viruses from
crossing the species barrier, the primary cause for the emergence of new
viruses.
Methods: Immunoprecipitation followed by differential proteomic analysis,
was implemented to probe PB2627K-associated (human) and PB2627E-associ-
ated (avian signature) proteins and identify copurifying proteins through
mass spectrometry. This interaction and its possible effect on the PB2
627E polymerases were investigated using PB2 copurification experiments
and viral polymerase activity assays.
Results: The elongation factor Tu, mitochondrial (TUFM) exhibited a higher
binding affinity to PB2627E. Knocking down the TUFM restored viral mRNA
synthesis, which was attenuated by PB2 K627E substitution in human cells.
Similarly, regarding the PB2627K/E for the general influenza A strains, a
stronger binding of the TUFM to avian signatures PB2590G/591Q and PB2627E
was evident in the 2009 pandemic H1N1 and the new H7N9 influenza A vi-
ruses. The TUFM exhibited a differential binding affinity to PB2 627K/E
that exerted various inhibitory effects on the viral RNA polymerase activity,
which is critical for viral replication in host cells.
